Disease Burden of Pancreatic Cancer — China, 1990−2019

WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? Pancreatic cancer is one of the most malignant tumors of the digestive tract, and the etiology is not clear. Pancreatic cancer has a poor prognosis and high mortality. WHAT IS ADDED BY THIS REPORT? Compared with 1990, the burden of pancreatic cancer in China i...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Yuan, Zhou, Xiaolong, Fan, Xueqi, Zhang, Bin, Ma, Li, Wu, Jing, Li, Xudong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022
Materias:
Preplanned Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257688/
https://www.ncbi.nlm.nih.gov/pubmed/35812697
http://dx.doi.org/10.46234/ccdcw2022.056
Descripción
Sumario:WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? Pancreatic cancer is one of the most malignant tumors of the digestive tract, and the etiology is not clear. Pancreatic cancer has a poor prognosis and high mortality. WHAT IS ADDED BY THIS REPORT? Compared with 1990, the burden of pancreatic cancer in China increased significantly in 2019. In 1990 and 2019, the disease burden indicator of male pancreatic cancer was higher than that of females, and pancreatic cancer became more common as age increased, especially above 50 years old. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICES? This study mainly provided scientific data and references for the prevention and control of pancreatic cancer in people aged 50 and above.

Ejemplares similares